Cited by 563Cancer Cells and MetastasisCancer Genomics and DiagnosticsMechanisms of cancer metastasis

Origins of Metastatic Traits

Open access
Vanharanta, Sakari, Massagué, Joan·2013·Cancer Cell

Abstract

How cancer cells acquire the competence to colonize distant organs remains a central question in cancer biology. Tumors can release large numbers of cancer cells into the circulation, but only a small proportion of these cells survive on infiltrating distant organs and even fewer form clinically meaningful metastases. During the past decade, many predictive gene signatures and specific mediators of metastasis have been identified, yet how cancer cells acquire these traits has remained obscure. Recent experimental work and high-resolution sequencing of human tissues have started to reveal the molecular and tumor evolutionary principles that underlie the emergence of metastatic traits.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ccr.2013.09.007

Cites

132 of 132 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Cancer stem cells are thought to be resistant to targeted therapies and responsible for metastasis, disease recurrence and poor outcomes.

    “Cancer stem cells (CSCs) are thought to be resistant to targeted therapies and responsible for metastasis, disease recurrence and poor outcomes [42, 45].”

    From An integrative gene expression signature analysis identifies CMS4 KRAS-mutated colorectal cancers sensitive to combined MEK and SRC targeted therapy (2022) · cites this paper as [42]

    In “Sources of Influence: Germline, Plasticity, Stroma, and Therapy” (page unavailable), the review says a more stem-like phenotype may help cells through metastatic bottlenecks and that EMT has been proposed to confer stemness and therapy resistance together. It does not specifically establish CSC resistance to targeted therapies or attribute disease recurrence and poor outcomes to CSCs. “Metastasis Bottlenecks” (page unavailable) also cautions that individually circulating CSCs would probably not form metastases. (LLM, conf=0.86)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

3 retracted

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Vanharanta, S., & Massagué, J.
Affiliations
Memorial Sloan Kettering Cancer Center (US)
Corresponding author
Massagué, Joan
Venue
Cancer Cell
Publisher
Elsevier BV
Published
2013-10
Volume
24
Issue
4
Pages
410-421
ISSN
1535-6108 (ISSN-L)
OpenAlex
W2071732560
Cited by
563
References
132
Citations by year
2026: 10 · 2025: 22 · 2024: 54 · 2023: 43 · 2022: 35 · 2021: 57 · 2020: 54 · 2019: 48 · 2018: 63 · 2017: 51 · 2016: 53 · 2015: 49 · 2014: 23
FWCI
4.41
Type
journal article
Language
en
Open access
Locations
  • Cancer Cell (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • U.S. Department of Defense
  • Howard Hughes Medical Institute
  • National Institutes of Health
  • U.S. Public Health Service (U54-163167)
  • Medical Research Council (MC_UU_12022/7)
  • National Cancer Institute (P01-CA94060, R37-CA34610, R37CA034610, P01CA129243, P01CA094060, U54CA163167, P30CA008748)
Topics
  • Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mechanisms of cancer metastasis
Keywords
metastasis, tumor evolution, cancer cell dissemination, tumor heterogeneity, cancer genomics
MeSH terms
Animals, Breast Neoplasms, Cell Transformation, Neoplastic, Disease Models, Animal, Female, Humans, Male, Neoplasm Metastasis, Phenotype, Prostatic Neoplasms, Stochastic Processes, Disease Progression, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review